Improve the odds of your candidate becoming a drug
Around 90% of all biotherapeutic candidates fail during clinical development stages. If preclinical stages are…
Monolith
Alternative energy source – Learning from bacteria
Phosphorus is absolutely necessary for all life on the planet. It is present in DNA,…
Two powerhouses join forces to examine how oxidation affects antibody therapeutics
Antibodies are one of the most common types of drugs in the biopharmaceutical industry and play a key…
Label-free MST takes a deeper look at bacteria’s vulnerable site and reveals potential druggable target
A group from the University of Gothenburg recently published a functional characterization of a bacterial…
In the wild! Characterizing protein variants in native environment uncovers risk for large artery atherosclerotic stroke
Proteins don’t always behave the way they do in their natural environment when studied in…
Finally free! Characterizing binding affinity directly in cell lysates speeds up understanding of tumor immunology
Binding assays are the primary windows for elucidating protein interactions associated with cancer and are…
Why being highly sensitive is a good thing – Measuring RNA-ligand binding interactions using less sample
RNA molecules come in different shapes and sizes and regulate all kinds of biological processes.…
Using Monolith, Axolabs overcomes 3 downsides of traditional methods to measure CRISPR/Cas9 interactions
Optimizing CRISPR/Cas9 interactions for therapeutic approaches requires that the binding affinities of diverse RNA constructs…
Overcoming hurdles to study Fc and Fab binding interactions
Characterizing high affinity interactions between antibodies and their binding partners can bring up technical challenges.…